Stock Evaluator: CONMED Corporation (CNMD)

CONMED Corporation CNMD

$46.01 -0.97 -2.06%
July 31, 2026 12:01:03 PM EST November 10, 2021 Volume: 147,507
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NYSE | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

Commentary & Analysis


Financial Summary

Share Statistics CNMD Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $1,407.1 $334.8 49%
Shares Out (Mil) 30.1 41.7 37%
Institutional Ownership 99.2% 77.3% 86%
Float (Mil) 29.7 34.7 36%
Beta 0.93 0.86 55%
Avg Daily Volume (000s) 632 266 63%
Price Change
(52-week)
(6.6%) 60.7% 40%
Growth CNMD Industry
Median
Percentile
(All Stocks)
Sales (5yr) 9.8% 11.8% 57%
Net Income (5yr) 37.7% (5.8%) 89%
EPS (5yr) 36.4% 10.7% 86
Dividends (5yr) (5.6%) 0.0% 71%
Cash Flow (5yr) 60.3% (16.1%) 95%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 7 7 7
Current EPS $1.003 $4.536 $4.782
Month Ago EPS $1.035 $4.362 $4.766
# Rev Up 2 1 1
# Rev Down 0 0 0
Three Months Ago EPS $1.043 $4.372 $4.846
Year/Year Chg 30.8% 200.4% 257.2%
Financials CNMD Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $1,372 $152 55%
Net Income (TTM) (Mil) $57 ($11) 56%
EPS (TTM) $1.841 ($0.500) 70%
Operating Cash Flow (TTM) (Mil) $151 ($2) 56%
Net Cash Flow (TTM) (Mil) $3 $1 51%
Long-Term Debt (Q1) (Mil) $657 $22 62%
Enterprise Value (Q1) (Mil) $2,098 $304 50%
Valuation CNMD Industry
Median
Percentile
(All Stocks)
P/B 1.35 2.88 35%
P/E 25.5 30.5 62%
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) 0.7 1.9 33%
Ratios CNMD Industry
Median
Percentile
(All Stocks)
Gross Margin 55.1% 59.1% 67%
Net Margin 4.1% (7.7%) 46%
ROA 2.4% (13.7%) 58%
ROE 5.5% (15.9%) 45%
Liabilities to Assets 54.7% 44.9% 47%
F-Score 7 4 84%

Passing Stock Screens

As of 7/30/2026, from a list of 60 stock screening strategies, CNMD meetings the criteria of 3 screen:

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors